Gastroparesis Trial, Recruiting NCT05981300 Sponsor: Johns Hopkins Bloomberg School of Public Health Condition: Gastroparesis
Back to Gastroparesis

Gastroparesis Trial, Recruiting

NCT05981300
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to sign a consent form and agree to follow all study procedures for the full duration of the trial
  • You are between 8 and 25 years old at the time of joining
  • You have had symptoms such as nausea, vomiting, feeling full quickly, feeling full after eating, or upper stomach pain for at least 12 weeks
  • You have had a specific stomach-emptying scan (using an egg-based meal) within the last 12 months, and either: the scan showed your stomach empties more slowly than normal, OR your stomach empties at a normal speed but you still have the above symptoms or have previously taken part in the Pediatric Gastroparesis Registry study
  • Your stomach symptoms are caused by either diabetes or an unknown cause (idiopathic)

Who may not be able to join:

  • You are unable to complete the stomach-emptying scan, including if you have an egg allergy
  • You are currently pregnant
  • You have autism spectrum disorder, significant developmental delays, or psychosis, as these may make it difficult to complete the study questionnaires (confirm with trial site)
  • You use narcotic (opioid) painkillers more than three days per week
  • You have a condition that causes inflammation or damage to the digestive tract lining, such as inflammatory bowel disease, stomach ulcers, celiac disease, or certain allergic gut conditions
  • You have another condition (unrelated to gastroparesis) that could also cause your stomach to empty slowly
  • You have a confirmed blockage anywhere in your digestive tract
  • You have a brain or nervous system condition that could cause nausea and vomiting, such as raised pressure in the skull or a brain lesion
  • You have acute or chronic kidney failure, or you are on dialysis
  • You have acute liver failure or advanced liver disease
  • You have a significant congenital (present from birth) heart condition (confirm with trial site)
  • You have had surgery on your esophagus, stomach, or bowel in the past
  • You have a metabolic disease, such as mitochondrial disease or an inherited metabolic disorder
  • You have a chronic lung disease, including cystic fibrosis
  • You have another serious ongoing medical condition, such as inflammatory bowel disease
  • You are taking medications that affect how your digestive system moves food during the stomach-emptying scan
  • You have any other condition that the study doctor believes could explain your symptoms or interfere with the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Geoffrey Preidis, MD, PhD, Baylor College of Medicine

Phone: 410-955-4165

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Johns Hopkins Bloomberg School of Public Health
Registry
ClinicalTrials.gov
Start date
18 December 2024
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in mean symptom severity of gastrointestinal symptoms using the change in total score from the Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Symptoms Scales™

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov